Anixa Biosciences Inc (ANIX)

NASDAQ
3.100
+0.030(+0.98%)
After Hours
3.280
+0.180(+5.806%)
- Real-time Data
  • Volume:
    87,785
  • Bid/Ask:
    3.110/3.270
  • Day's Range:
    3.070 - 3.280

ANIX Overview

Prev. Close
3.07
Day's Range
3.07-3.28
Revenue
510K
Open
3.13
52 wk Range
2.71-8.09
EPS
-0.45
Volume
87,785
Market Cap
93.41M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
167,207
P/E Ratio
-
Beta
1.55
1-Year Change
-21.12%
Shares Outstanding
30,132,319
Next Earnings Date
Mar 11, 2022
What is your sentiment on Anixa Biosciences Inc?
or
Market is currently closed. Voting is open during market hours.

Anixa Biosciences Inc Company Profile

Employees
0

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company’s therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellSellStrong Sell
Technical IndicatorsStrong SellStrong SellBuySellSell
SummaryStrong SellStrong SellNeutralSellStrong Sell
  • http://www.openinsider.com/ ANIX is listed as a recent "cluster buy"... someone bought 90,600 shares at $4.58. Not investment advice... Just pointing this out.
    0
    • Ding *******sing a song, time to go long like Ching Xhong with a *******in a thong
      1
      • Ignore that.. Just go long and wait 6+months for the magic... This could be a once in a century discovery here.. cash runway 16-24 months no debts what so ever, a CEO with great track record, DoD backing, Cleveland Clinic collobaration etc etc, just WOW. Let’s make a fortune. Do your own DD, but let’s face it - Won’t get much bettet then this RR wise... Glta
        0
    • Still holding
      0
      • Monday should be a very good day. Fingers crossed.
        0
    • Anyone still holding?
      0
      • Debating to sell, lot of drops .
        0
    • Falling like a friggin rock now.
      0
      • I shoulda sold it.
        0
        • Are u holding through Sept 27?
          0
          • I just made good money on this one
            0
            • Are u holding through sept 27?
              0
            • good for you.!!!
              0
          • Í justo made gold money on this one
            0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.